维普中文期刊产品整合服务
37篇 您的检索式:作者名="Cheok M"
    题名 作者 年代 出处 被引量
1Accumulation of nutrients and heavy metals in surface sediments near Macau 显示文摘Ferreira F M Chiu W S Cheok H K etal 1996Marine Pollution Bulletin1996,32,5:1
2Accumulation of nutrients and heavy metals in surface sediments near Macao显示文摘 Chiu W S Cheok H K 1996Marine Pollution Balletin1996,32,:1
3Biological nitrogen removal with enhanced phosphate uptake in a sequencing batch reactor using single sludge system显示文摘Dae S L CHEOk J JONG M P et aI 2001Water Research2001,35,16:1
4TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs)显示文摘KOSMIDER O GELSI-BOVFR V CHEOK M 2009Blood2009,114,15:1
5TET2mutation is an independent favorable prognos-tic factor in myelodysplastic syndromes(MDSs)显示文摘KOSMIDER O GELSI-BOYER V CHEOK M 2009Blood2009,114,:1
6Fast Automatic Registration of Range Images from 3D Imaging Systems Using Sphere Targets 显示文摘FRANASZEK M CHEOK G S WITZGALL C 2009Automation in Construction2009,18,3:1
7Pentachlorophenol dechlorination by an acidogenic sludge显示文摘CHEOK H M HE J Z WUN J N 2008Wator Research2008,42,14:1
8Folate pathway gene expression differs in suntypes of acute lymphoblastic leukemia and influences methotrexate pharmacodynamics显示文摘Kager L Cheok M Yang W 2005J Clin Invest2005,115,1:1
9Folate pathwaygene expression differs in subtypes of acute lymphoblastic leukemia and influences methotrexated pharmacodynamics显示文摘KAGER L CHEOK M YANG W T 2005J Clin Invest2005,115,1:1
10TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDS)显示文摘Kosmider O Gelsi-Boyer V Cheok M 2009Blood2009,114,:1
11Use of importance measures in riskinformed regulatory applications显示文摘Cheok M C Parry G W Sherry R R 1998Reliab Eng Syst Saf1998,60,:1
12TET2 mutation is an independent favorable prognos- tic factor in myelodysplastic syndromes (MDSs)显示文摘KOSMIDER O GELSI-BOYER V CHEOK M 2009Blood2009,114,:1
13Reviewing pf pregnancy labeling of prescription drugs: Is the current system adequate to inform of risks?显示文摘DOSERING P BOOTHBY L A CHEOK M 2002Am J Obstet Gynecol2002,187,2:1
14Folate pathway gene expression differs in subtypes of acute lymphoblastic leukemia and influences methotrexate pharmacodynamics 显示文摘Kager L Cheok M Yang W 2005J Clin Invest2005,115,1:1
15Use of importance meas- ures in risk-informed regulatory applications 显示文摘CHEOK M C PARRY G W SHERRY R R 1998Reliability Engi- neering & System Safety1998,60,3:1
16Genetic polymorphism of inosine triphosphate pyrophosphatase is a determinant of mercaptopurine metabolism and toxicity during treatment for acute lymphoblastic leukemia显示文摘Stocco G Cheok M H Crews K R 2009Clin Pharmacol Ther2009,85,2:1
17A subtype of childhood acute lymphoblastic leukemia with poor treatment outcome: a genome- wide classification study显示文摘Den Boer ML van Slegtenhorst M De Menezes RX Cheok MH Buijs-Gladdines JG Peters ST 2009Lancet Oncol2009,10,2:1
18Characteristics and treatments of large cystic brain metastasis:radiosurgery and stereotactic aspiration显示文摘Kim M Cheok S Chung L K 2015Brain Tumor Res Treat2015,3,1:1
19Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment 显示文摘Holleman A Cheok M H den Boer M L 2004N Engl J Med2004,351,6:1
20TET2 mutation is an Independent favorable prognostic factor in myelodysplastic syndromes (MDSs)显示文摘Kosmider O Gelsi-Boyer V Cheok M 2009Blood2009,114,15:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费